Action UTHR UNITED THERAPEUTICS CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues United Therapeutics Corporation

Actions

UTHR

US91307C1027

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
233,8 USD -0,89% Graphique intraday de United Therapeutics Corporation -1,71% +6,35%
23/04 Un initié de United Therapeutics a vendu des actions pour une valeur de 1 704 174 $, selon un récent dépôt auprès de la SEC MT
19/04 Un initié de United Therapeutics a vendu des actions pour une valeur de 1 704 990 $, selon un récent dépôt auprès de la SEC MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing
United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says
United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling
United Therapeutics Corporation Announces Extension of Credit Agreement
United Therapeutics Insider Sold Shares Worth $7,375,339, According to a Recent SEC Filing
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
United Therapeutics Corporation announces an Equity Buyback for $1,000 million worth of its shares.
United Therapeutics Insider Sold Shares Worth $7,100,981, According to a Recent SEC Filing
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action UTHR
  4. Actualités United Therapeutics Corporation
  5. Autres langues